Insider Shareholders with Direct Ownership of Alnylam Pharmaceuticals, Inc. (ALNY)
This section provides a comprehensive overview of the insiders with direct ownership of Alnylam Pharmaceuticals, Inc. (ALNY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ALNYLAM PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John Maraganore
Chief Executive Officer |
220,616 | 190,542 | 227,663 $102 Million | 17 |
Dec 22, 2021
Reduced 0.14%
|
|
Yvonne Greenstreet
Chief Executive Officer |
356,873 | 292,708 | 68,985 $31 Million | 52 |
Nov 26, 2025
Reduced 1.6%
|
|
Jeffrey V. Poulton
EVP, Chief Financial Officer |
78,916 | 24,864 | 54,052 $24.3 Million | 27 |
Oct 02, 2025
Reduced 0.01%
|
|
Tolga Tanguler
EVP, Chief Commercial Officer |
54,437 | 26,999 | 27,438 $12.3 Million | 30 |
Oct 02, 2025
Reduced 0.0%
|
|
Akshay Vaishnaw
President |
102,953 | 94,298 | 22,774 $10.2 Million | 25 |
Aug 04, 2023
Reduced 0.84%
|
|
Kevin Joseph Fitzgerald
CSO & EVP, Head of Research |
55,925 | 47,542 | 21,264 $9.55 Million | 21 |
Nov 17, 2025
Reduced 1.37%
|
|
Pushkal Garg
EVP Chief R&D |
129,296 | 120,267 | 20,221 $9.08 Million | 40 |
Oct 03, 2025
Reduced 1.05%
|
|
Michael W Bonney
Director |
75,752 | 58,948 | 16,804 $7.55 Million | 9 |
Aug 18, 2025
Reduced 40.1%
|
|
Bryan Supran
EVP, CLO and Secretary |
13,026 | 0 | 13,026 $5.85 Million | 1 |
Oct 01, 2025
Added 50.0%
|
|
Amy W Schulman
Director |
42,161 | 30,200 | 11,961 $5.37 Million | 7 |
May 08, 2025
Added 6.09%
|
|
Robert W. Hesslein
EVP, CLO and Secretary |
8,002 | 0 | 8,002 $3.59 Million | 2 |
Mar 03, 2025
Added 8.64%
|
|
Laurie Keating
EVP, Chief Legal Officer |
49,464 | 47,324 | 5,132 $2.31 Million | 14 |
Aug 05, 2021
Reduced 66.09%
|
|
Indrani Lall Franchini
EVP, CLO & Secretary |
11,228 | 7,095 | 4,133 $1.86 Million | 7 |
Feb 28, 2024
Reduced 0.02%
|
|
Steven M Paul
Director |
30,000 | 30,000 | 1,000 $449,160 | 4 |
Apr 01, 2022
Reduced 14.89%
|
|
Dennis A Ausiello
Director |
75,109 | 74,198 | 911 $409,184 | 8 |
Aug 14, 2025
Reduced 41.3%
|
|
David E I Pyott
Director |
40,801 | 39,890 | 911 $409,184 | 6 |
May 08, 2025
Added 45.97%
|
|
Margaret A Hamburg
Director |
911 | 0 | 911 $409,184 | 2 |
May 08, 2025
Added 45.97%
|
|
Carolyn R Bertozzi
Director |
775 | 0 | 775 $348,099 | 1 |
May 08, 2025
Added 50.0%
|
|
Charles Elliott Sigal
Director |
775 | 0 | 775 $348,099 | 1 |
May 08, 2025
Added 50.0%
|
|
Olivier Brandicourt
Director |
775 | 0 | 775 $348,099 | 1 |
May 08, 2025
Added 50.0%
|
|
Colleen F Reitan
Director |
18,811 | 18,036 | 775 $348,099 | 6 |
Sep 09, 2025
Reduced 3.13%
|
|
Peter N Kellogg
Director |
775 | 0 | 775 $348,099 | 1 |
May 08, 2025
Added 50.0%
|
|
Marsha Fanucci
Director |
136 | 0 | 136 $61,085 | 1 |
Feb 23, 2023
Added 50.0%
|
|
Phillip A Sharp
Director |
134,920 | 370,553 | 0 $0 | 11 |
Jan 23, 2025
Reduced 100.0%
|